Literature DB >> 1661735

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.

P Kristensen1, J Eriksen, F Blasi, K Danø.   

Abstract

Two mouse urokinase-type plasminogen activator receptor (muPAR) cDNAs were isolated: muPAR1 is homologous to the human urokinase-type plasminogen activator receptor while muPAR2 codes for a 199 residue protein sharing the first 133 residues with muPAR1. Mouse genomic DNA sequencing indicates that the two different mRNAs arise by alternative splicing. In situ hybridization showed differential expression of the two mRNAs in mouse gastric mucosa. muPAR1 mRNA is located in luminal epithelial cells situated close to urokinase-type plasminogen activator-producing connective tissue cells of the lamina propria, pointing to plasmin generation controlled by the cooperation of different cells that may play a role in the release of gastric epithelial cells. muPAR2 mRNA is expressed in the basal epithelial cells, and the deduced protein sequence includes the receptor ligand binding domain, but omits the region involved in glycolipid-mediated membrane anchoring, suggesting that muPAR2 may code for a secreted uPA binding protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661735      PMCID: PMC2289218          DOI: 10.1083/jcb.115.6.1763

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  56 in total

1.  Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

Authors:  S C Seifert; T D Gelehrter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

Review 2.  Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures.

Authors:  M A Ferguson; A F Williams
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 3.  Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors.

Authors:  R R Schleef; D J Loskutoff
Journal:  Haemostasis       Date:  1988

4.  Cloning and expression of a cDNA for the T-cell-activating protein TAP.

Authors:  H Reiser; J Coligan; E Palmer; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Squid glycoproteins with structural similarities to Thy-1 and Ly-6 antigens.

Authors:  A F Williams; A G Tse; J Gagnon
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.

Authors:  S Strickland; E Reich; M I Sherman
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

8.  Alternative splicing generates a secreted form of N-CAM in muscle and brain.

Authors:  H J Gower; C H Barton; V L Elsom; J Thompson; S E Moore; G Dickson; F S Walsh
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

9.  The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor.

Authors:  W R Baumbach; D L Horner; J S Logan
Journal:  Genes Dev       Date:  1989-08       Impact factor: 11.361

10.  Serine enzymes released by cultured neoplastic cells.

Authors:  K Danø; E Reich
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  21 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

Authors:  Kasper Almholt; Ole Didrik Lærum; Boye Schnack Nielsen; Ida Katrine Lund; Leif Røge Lund; John Rømer; Annika Jögi
Journal:  Clin Exp Metastasis       Date:  2015-06-04       Impact factor: 5.150

3.  uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.

Authors:  Changli Wei; Jing Li; Brian D Adair; Ke Zhu; Jian Cai; Michael Merchant; Beata Samelko; Zhongji Liao; Kwi Hye Koh; Nicholas J Tardi; Ranadheer R Dande; Shuangxin Liu; Jianchao Ma; Salvatore Dibartolo; Stefan Hägele; Vasil Peev; Salim S Hayek; David J Cimbaluk; Melissa Tracy; Jon Klein; Sanja Sever; Sanford J Shattil; M Amin Arnaout; Jochen Reiser
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

4.  Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.

Authors:  N Busso; V Péclat; A So; A P Sappino
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

5.  Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.

Authors:  T Teesalu; A E Hinkkanen; A Vaheri
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

7.  Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.

Authors:  L R Lund; V Ellis; E Rønne; C Pyke; K Danø
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.

Authors:  Marc Tjwa; Nicolai Sidenius; Rute Moura; Sandra Jansen; Koen Theunissen; Annapaola Andolfo; Maria De Mol; Mieke Dewerchin; Lieve Moons; Francesco Blasi; Catherine Verfaillie; Peter Carmeliet
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

9.  A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

Authors:  N Pedersen; M Schmitt; E Rønne; M I Nicoletti; G Høyer-Hansen; M Conese; R Giavazzi; K Dano; W Kuhn; F Jänicke
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

Authors:  Heng Wang; John Hicks; Parham Khanbolooki; Sun-Jin Kim; Chunhong Yan; Yao Wang; Douglas Boyd
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.